Why do patients fail to receive β-blockers for chronic heart failure over time? A “real-world” single-center, 2-year follow-up experience of β-blocker therapy in patients with chronic heart failure

Utilization rates of β-blockers in our heart failure clinic have remained constant at approximately 70% throughout a 2-year follow-up. Of those who discontinued β-blockers (10%), the most common documented cause was failure to restart β-blockers after hospitalization.